You might have already guessed this from the coughs and sniffles around you, but a lot of people are sick right now, and a lot of them have COVID. According…
-
-
Emilio Morenatti / AP Diego Meneses, of Colombia, competes in the Men’s Javelin Throw F34 Final at the Stade de France stadium during the 2024 Paralympics, on September 4, 2024.…
-
Steph Chambers / Getty Kinga Dróżdż of Team Poland competes against Xufeng Zou of Team China during the Women’s Sabre Category A fencing quarterfinals on day six of the Paris…
-
Researchers at the Mount Sinai Hospital have developed an mRNA-based treatment for cancer. The approach combines the delivery of mRNA therapy in lipid nanoparticles and also involves co-delivering dendritic cells…
-
Researchers at the Mount Sinai Hospital have developed an mRNA-based treatment for cancer. The approach combines the delivery of mRNA therapy in lipid nanoparticles and also involves co-delivering dendritic cells…
-
Researchers at the Terasaki Institute for Biomedical Innovation in Los Angeles have developed a gelatin-based surgical sealant. The sealant is thermoresponsive, meaning that it will rapidly form a semi-solid bolus…
-
Researchers at the Terasaki Institute for Biomedical Innovation in Los Angeles have developed a gelatin-based surgical sealant. The sealant is thermoresponsive, meaning that it will rapidly form a semi-solid bolus…
-
Researchers at the Terasaki Institute for Biomedical Innovation in Los Angeles have developed a gelatin-based surgical sealant. The sealant is thermoresponsive, meaning that it will rapidly form a semi-solid bolus…
-
Researchers at the Terasaki Institute for Biomedical Innovation in Los Angeles have developed a gelatin-based surgical sealant. The sealant is thermoresponsive, meaning that it will rapidly form a semi-solid bolus…
-
Researchers at the Terasaki Institute for Biomedical Innovation in Los Angeles have developed a gelatin-based surgical sealant. The sealant is thermoresponsive, meaning that it will rapidly form a semi-solid bolus…